A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
Browsing: Pharmacology
Northwestern Medicine scientists have discovered how circulating tumor cells cluster together during metastasis — findings that reveal a novel mechanism for how cancer spreads and a potential new target for treatment.
According to a recent study, a group of four gene mutations seen only in people with African ancestry may contribute to an increased risk of severe bleeding while taking warfarin.
Targeting cancer cells with a transcription elongation inhibitor delayed tumor progression in animal models, according to a recent Northwestern Medicine study.
Gemma Carvill, PhD, assistant professor of Neurology, has been named a recipient of the NIH Director’s New Innovator Award, which funds highly innovative research proposals with the potential to transform their field.
Northwestern has been awarded a $12 million, five-year grant from the NIH for a research center dedicated to advancing the genetic understanding of epilepsy.
Northwestern Medicine scientists are using a variety of innovative techniques to uncover the epigenetics of breast cancer, as seen in three recent studies.
Northwestern Medicine scientists have discovered the activation mechanism of a calcium channel, providing new insights for future drug development targeting this calcium signaling pathway.
Novel research is changing the way we approach healthcare for mothers and their babies. Read the feature in Northwestern Medicine magazine.
A Northwestern Medicine study has expanded the understanding of nicotine’s influences on the brain’s reward pathway, with implications for the development of anti-addiction therapies.